Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-09

Clinical Trial Update: A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

View source ↗

Summary

Clinical trial update for GANFORT UD in primary open-angle glaucoma or ocular hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GANFORT UD

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2015-12-09